American Funds' Greatest Hits

Recs

4

Few fund families have amassed the name recognition and sheer assets of American Funds. This behemoth ranks among the nation's top three fund families, currently boasting more than $900 billion in net assets. American Funds and its subadvisor, Capital Research & Management, have assembled an impressive stable of funds, some of which particularly deserve investors' attention. We'll spotlight some of these funds below.

Growth Fund of America (AGTHX)
Growth Fund of America is the largest mutual fund in existence, with almost $177 billion in net assets. This fund has reached such colossal heights because few similar funds can match its performance record. Despite its moderate-growth orientation, this fund has managed to keep pace with, and even beat, the broader market in recent years. Growth Fund's long-term track record is also impressive, posting a 12.9% annualized 10-year return through May 31, 2007, compared to just 7.8% for the S&P 500. Its consistency is also remarkable, having landed in the top half of its peer group in every calendar year for the past 10 years.

Growth Fund focuses on large-cap stocks with high growth potential, such as current top holdings Microsoft (Nasdaq: MSFT) and Google (Nasdaq: GOOG). The fund currently sports low expenses and low turnover, two more points in its favor. Growth Fund does tend to hold a lot of cash (currently 9% of assets), so returns will likely lag in momentum-led growth rallies. Still, that's actually worked in the fund's favor recently.

As with all American Funds, Growth Fund is run using Capital Research & Management's multiple portfolio counselor system. Several managers each control their own independent sleeve of the portfolio, with new counselors added as inflows increase. At some point, this fund will begin to bump up against capacity constraints; for now, it seems that Growth Fund has plenty of room to run.

Europacific Growth (AEPGX)
Decent international funds with established track records are few and far in between. Europacific Growth Fund is one of them. This globetrotter invests mainly in companies found in Europe and the Pacific Basin, with Bayer (NYSE: BAY) and AXA (NYSE: AXA) currently composing some of its top holdings. Europacific Growth currently employs eight portfolio counselors, four of whom have been with the fund since at least the mid-1990s.

With the exception of 1999, in which the fund posted a nearly 57% gain, returns have been solid, but not spectacular. For the 10-year period ending May 31, 2007, the fund was up an annualized 11.3%, versus 8.2% for the benchmark MSCI EAFE Index. Europacific Growth also holds a slug of emerging-market names, so it can be affected by the ebb and flow of this  segment. All in all, it's a solid choice for investors seeking a broadly diversified foreign fund.

Income Fund of America (AMECX)
If you're looking for a balanced fund that holds both stocks and bonds, the Income Fund of America might be right up your alley. It employs five portfolio counselors on the equity side, and four counselors to find fixed-income securities. Income Fund typically allocates between 50% and 60% of its portfolio to equity securities, never straying far from that range. It seeks stocks that pay above-average dividends, such as top holdings AT&T (NYSE: T) and Chevron (NYSE: CVX). Income Fund also dedicates a decent amount of space to high-yield issues on the fixed-income side.

Income Fund has posted an annualized 10.1% return for the 10-year period ending May 31, 2007. That's pretty impressive for a fund holding roughly half of its assets in fixed-income securities. It's even more striking that the fund has lost money in only three out of the last 30 calendar years. Talk about protection of capital! It's rare to find a balanced mutual fund that can protect investors well during downturns, yet still provide competitive equity returns. Income Fund of America manages to do both.

American Funds has many fine offerings, but if you're considering buying into this fund family, start your search with these three candidates. They're outstanding examples of American Funds' overall excellence.

Related articles:

The Fool's Champion Funds newsletter can help you discover which funds might be right for your portfolio. Start your free 30-day trial today.

Fool contributor Amanda Kish lives in Rochester, N.Y., and does not own shares of any of the companies or funds mentioned herein. Microsoft is an Inside Value recommendation. The Fool has an all-American disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 530413, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:50:55 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
AXA $25.78 Up +0.63 +2.51%
AXA (ADR) CAPS Rating: **
CVX $77.66 Up +0.13 +0.17%
Chevron Corp CAPS Rating: ****
T $26.34 Up +0.41 +1.58%
AT&T, Inc. CAPS Rating: ****
GOOG $562.51 Up +11.41 +2.07%
Google, Inc. CAPS Rating: ***
MSFT $28.99 Up +0.47 +1.65%
Microsoft Corp CAPS Rating: ***

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!